Management of FLT3-mutated AML typically involves standard treatment guidelines combining chemotherapy and FLT3 inhibitors, followed by allogeneic hematopoietic cell transplantation to improve the likelihood of promising outcomes [11]. This evidence concerns the gene FLT3 and acute myeloid leukemia.